Extracellular vesicle species differentially affect endothelial cell functions and differentially respond to exercise training in patients with chronic coronary syndromes.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
25 10 2021
Historique:
received: 07 01 2020
accepted: 27 03 2020
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 5 4 2022
Statut: ppublish

Résumé

Extracellular vesicles are released upon cellular activation and mediate inter-cellular communication. Individual species of extracellular vesicles might have divergent roles in vascular homeostasis and may show different responses to therapies such as exercise training. We examine endothelial effects of medium-size and small extracellular vesicles from the same individual with or without chronic coronary syndrome, and in chronic coronary syndrome patients participating in a four-week high-intensity interval training intervention. Human aortic endothelial cells were exposed to medium-size extracellular vesicles and small extracellular vesicles isolated from plasma samples of study participants. Endothelial cell survival, activation and re-endothelialisation capacity were assessed by respective staining protocols. Extracellular vesicles were quantified by nanoparticle tracking analysis and flow cytometry. Extracellular vesicle microRNA expression was quantified by realtime-quantitative polymerase chain reaction. In patients with chronic coronary syndrome (n = 25), plasma counts of leukocyte-derived medium-size extracellular vesicles were higher than in age-matched healthy controls (n = 25; p = 0.04) and were reduced by high-intensity interval training (n = 15; p = 0.01 vs baseline). Re-endothelialisation capacity was promoted by medium-size extracellular vesicles from controls, but not by medium-size extracellular vesicles from chronic coronary syndrome patients. High-intensity interval training for 4 weeks enhanced medium-size extracellular vesicle-mediated support of in vitro re-endothelialisation. Small extracellular vesicles from controls or chronic coronary syndrome patients increased endothelial cell death and reduced repair functions and were not affected by high-intensity interval training. The present study demonstrates that medium-size extracellular vesicles and small extracellular vesicles differentially affect endothelial cell survival and repair responses. This equilibrium is unbalanced in patients with chronic coronary syndrome where leukocyte-derived medium-size extracellular vesicles are increased leading to a loss of medium-size extracellular vesicle-mediated endothelial repair. High-intensity interval training partially restored medium-size extracellular vesicle-mediated endothelial repair, underlining its use in cardiovascular prevention and therapy to improve endothelial function.

Sections du résumé

BACKGROUND
Extracellular vesicles are released upon cellular activation and mediate inter-cellular communication. Individual species of extracellular vesicles might have divergent roles in vascular homeostasis and may show different responses to therapies such as exercise training.
AIMS
We examine endothelial effects of medium-size and small extracellular vesicles from the same individual with or without chronic coronary syndrome, and in chronic coronary syndrome patients participating in a four-week high-intensity interval training intervention.
METHODS
Human aortic endothelial cells were exposed to medium-size extracellular vesicles and small extracellular vesicles isolated from plasma samples of study participants. Endothelial cell survival, activation and re-endothelialisation capacity were assessed by respective staining protocols. Extracellular vesicles were quantified by nanoparticle tracking analysis and flow cytometry. Extracellular vesicle microRNA expression was quantified by realtime-quantitative polymerase chain reaction.
RESULTS
In patients with chronic coronary syndrome (n = 25), plasma counts of leukocyte-derived medium-size extracellular vesicles were higher than in age-matched healthy controls (n = 25; p = 0.04) and were reduced by high-intensity interval training (n = 15; p = 0.01 vs baseline). Re-endothelialisation capacity was promoted by medium-size extracellular vesicles from controls, but not by medium-size extracellular vesicles from chronic coronary syndrome patients. High-intensity interval training for 4 weeks enhanced medium-size extracellular vesicle-mediated support of in vitro re-endothelialisation. Small extracellular vesicles from controls or chronic coronary syndrome patients increased endothelial cell death and reduced repair functions and were not affected by high-intensity interval training.
CONCLUSION
The present study demonstrates that medium-size extracellular vesicles and small extracellular vesicles differentially affect endothelial cell survival and repair responses. This equilibrium is unbalanced in patients with chronic coronary syndrome where leukocyte-derived medium-size extracellular vesicles are increased leading to a loss of medium-size extracellular vesicle-mediated endothelial repair. High-intensity interval training partially restored medium-size extracellular vesicle-mediated endothelial repair, underlining its use in cardiovascular prevention and therapy to improve endothelial function.

Identifiants

pubmed: 34695219
pii: 6410040
doi: 10.1177/2047487320919894
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1467-1474

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Nicolle Kränkel (N)

Department of Cardiology, Charité-Universitätsmedizin Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Germany.
Berlin Institute of Health, Germany.
Center of Molecular Cardiology, University of Zurich, Switzerland.

Elisabeth Strässler (E)

Department of Cardiology, Charité-Universitätsmedizin Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Germany.
Berlin Institute of Health, Germany.
Center of Molecular Cardiology, University of Zurich, Switzerland.

Madlen Uhlemann (M)

Heart Center, University of Leipzig, Germany.

Maja Müller (M)

Department of Cardiology, University Hospital Zurich, Switzerland.

Sylvie Briand-Schumacher (S)

Center of Molecular Cardiology, University of Zurich, Switzerland.

Roland Klingenberg (R)

Department of Cardiology, University Hospital Zurich, Switzerland.

P Christian Schulze (PC)

Department of Internal Medicine I, University Hospital Jena, Germany.

Volker Adams (V)

Heart Center, University of Leipzig, Germany.
Heart Center Dresden, TU Dresden, Germany.

Gerhard Schuler (G)

Heart Center, University of Leipzig, Germany.

Thomas F Lüscher (TF)

Center of Molecular Cardiology, University of Zurich, Switzerland.
Heart Division, Royal Brompton and Harefield Hospitals, UK.

Sven Möbius-Winkler (S)

Heart Center, University of Leipzig, Germany.
Department of Internal Medicine I, University Hospital Jena, Germany.

Ulf Landmesser (U)

Department of Cardiology, Charité-Universitätsmedizin Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Germany.
Berlin Institute of Health, Germany.
Center of Molecular Cardiology, University of Zurich, Switzerland.
Department of Cardiology, University Hospital Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH